Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yo-ichi Matsubara
A Case of Postoperative Recurrence of Peritoneal Dissemination Due to Gastrointestinal Stromal Tumor of the Ileum Responding to Imatinib Mesylate
Japanese Journal of Gastroenterological Surgery
Surgery
Gastroenterology
A Case of Esophageal Cancer Associated With Postoperative Spontaneous Esophageal Rupture Twenty Years Earlier
Japanese Journal of Gastroenterological Surgery
Surgery
Gastroenterology
Related publications
A Case of Gastrointestinal Stromal Tumor of the Ileum With Intraabdominal Hemorrhage
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
A Case of Gastrointestinal Stromal Tumor of the Ileum Diagnosed by a Mesenteric Angiography.
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
Histone H2AX Is a Mediator of Gastrointestinal Stromal Tumor Cell Apoptosis Following Treatment With Imatinib Mesylate
Cancer Research
Cancer Research
Oncology
A Case of Perforation of the Terminal Ileum Due to Appendicitis That Repeated Recurrence
Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons)
Primary Prostatic Extra-Gastrointestinal Stromal Tumor Treated With Imatinib Mesylate as Neoadjuvant and Adjuvant Therapy: A Case Report and Literature Review
OncoTargets and Therapy
Oncology
Pharmacology
A Resected Case of Recurrence of an Esophageal Gastrointestinal Stromal Tumor in the Bone Nine Years After Esophagectomy and Metachronous Intestinal Gastrointestinal Stromal Tumor
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
The Economic Burden of Gastrointestinal Stromal Tumor (GIST) Recurrence in Patients Who Have Received Adjuvant Imatinib Therapy
Journal of Medical Economics
Health Policy
RACK1 Overexpression Is Linked to Acquired Imatinib Resistance in Gastrointestinal Stromal Tumor
Oncotarget
Oncology
Remarkable Response in a Case of Recurrent Gastrointestinal Stromal Tumor Treated With Low Dose Imatinib
Journal of Nihon University Medical Association
